Table 4.
Predictors of secondary complications.
| Bleeding Complications | Surgical Site Infection | Non-Home Discharge Destination | Medical Complications | Surgical Complications | |
|---|---|---|---|---|---|
| Variable | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) |
| Age | |||||
| 18-40 | Reference | Reference | Reference | Reference | Reference |
| 41-60 | 0.53 (0.2–1.37) | 1.17 (0.13–10.37) | 1.88 (1.08–3.28)* | 0.29 (0.06–1.36) | 0.83 (0.57–1.22) |
| 61-80 | 0.65 (0.26–1.65) | 1.5 (0.18–12.47) | 5.13 (2.95–8.89)* | 1.05 (0.26–4.14) | 0.98 (0.67–1.44) |
| >80 | 0.76 (0.28–2.04) | 0.88 (0.09–8.58) | 18.65 (10.52–33.06)* | 1.69 (0.39–7.34) | 1.34 (0.89–2.02) |
| Female | 1.1 (0.79–1.53) | 1.15 (0.59–2.24) | 1.54 (1.37–1.74)* | 1.29 (0.75–2.21) | 1.22 (1.09–1.37)* |
| Race | |||||
| Caucasian | Reference | Reference | Reference | Reference | Reference |
| African American | 1.33 (0.68–2.6) | 0.65 (0.14–2.95) | 1.39 (1.11–1.75) * | 1.21 (0.39–3.78) | 1.37 (1.11–1.7)* |
| Hispanic | 0.66 (0.26–1.67) | 0.43 (0.05–3.47) | 1.49 (0.98–2.24) | 0.33 (0.04–2.8) | 1.37 (0.94–1.99) |
| Other | 2.38 (0.5–11.36) | N/A | 0.87 (0.52–1.45) | 0 (0–0) | 1.44 (0.91–2.28) |
| Unknown | 1.95 (1.05–3.61)* | 0.67 (0.15–3.04) | 0.64 (0.5–0.83) * | 0.84 (0.29–2.49) | 1.21 (0.97–1.51) |
| Hypoalbuminemia | 2.14 (1.42–3.21)* | 2.87 (1.36–6.05)* | 2.07 (1.77–2.43) * | 2.4 (1.32–4.37)* | 2.37 (2.05–2.74)* |
| Preoperative Transfusion | 2.25 (0.86–5.93) | N/A | 1.96 (1.26–3.05) * | 0.48 (0.09–2.47) | 2.96 (2–4.39)* |
| Systemic Sepsis | 0.89 (0.43–1.82) | 0.15 (0.02–1.21) | 1.67 (1.14–2.44) * | 1.77 (0.69–4.52) | 1.26 (0.91–1.74) |
| Corticosteroid Use | 1.05 (0.55–2) | 0.94 (0.26–3.4) | N/A | 2.57 (1.13–5.85)* | 1.16 (0.93–1.44) |
| Smoker | 0.64 (0.38–1.05) | 0.92 (0.37–2.29) | 1.08 (0.9–1.3) | N/A | 0.82 (0.69–0.98)* |
| Open Wound | 0.98 (0.48–2.02) | 1.03 (0.3–3.52) | 1.47 (1.03–2.08) * | 1.06 (0.42–2.7) | 1.37 (1.01–1.87)* |
| On Dialysis | N/A | N/A | 2 (1.06–3.78) * | N/A | 0.72 (0.41–1.27) |
| Obese | 1.15 (0.81–1.63) | 2.68 (1.31–5.46)* | 1.02 (0.89–1.15) | N/A | 1.01 (0.9–1.15) |
| Hyponatremia | 1.05 (0.62–1.77) | 1.5 (0.61–3.67) | 1.25 (1.01–1.56) * | 1.65 (0.82–3.3) | 1.34 (1.1–1.64)* |
| Myocardial Infarction | N/A | N/A | N/A | 2.15 (0.33–14.03) | N/A |
| Congestive Heart Failure | N/A | N/A | N/A | 0.7 (0.12–4.14) | 1.18 (0.73–1.91) |
| Hypertension | N/A | N/A | 1.22 (1.07–1.39) * | 0.63 (0.35–1.11) | 1.09 (0.96–1.24) |
| Impaired Functional Status | 0.62 (0.38–1.01) | 2.35 (1.07–5.16)* | 2.84 (2.22–3.65) * | 0.93 (0.48–1.8) | 1.4 (1.14–1.72)* |
| Use of Emergency Services | N/A | N/A | 1.75 (1.2–2.56) * | 1.12 (0.39–3.22) | 0.95 (0.76–1.21) |
| Preoperative Dyspnea | 1.12 (0.65–1.92) | 1.82 (0.7–4.74) | 1.03 (0.8–1.33) | 0.42 (0.15–1.18) | 1.06 (0.9–1.25) |
| Diabetes | 1.07 (0.67–1.7) | 1.12 (0.47–2.66) | 1.36 (1.15–1.62) * | 1.9 (0.96–3.74) | 0.47 (0.24–0.94)* |
| Disseminated Cancer | N/A | N/A | N/A | 0.53 (0.05–5.63) | 1.43 (0.45–4.62) |
| Pneumonia | N/A | N/A | N/A | 1.5 (0.09–25.49) | 1.4 (1.12–1.77)* |
| COPD | N/A | N/A | 1.49 (1.17–1.91) * | 2.25 (0.95–5.32) | N/A |
| Chemotherapy | 1.65 (0.37–7.37) | 4.01 (0.62–25.94) | N/A | N/A | N/A |
| Bleeding Disorder | 0.83 (0.4–1.72) | 0.48 (0.1–2.19) | 1.4 (1.09–1.81) * | 2.39 (1–5.72) | 1.66 (1.33–2.09)* |
| Recent Weight Loss >10% | N/A | N/A | 1.81 (0.92–3.59) | 0.2 (0.01–2.72) | 1.32 (0.72–2.43) |
| Ascites | N/A | N/A | 2.87 (0.52–15.8) | N/A | 1.58 (0.37–6.76) |
* Significantly associated with complication, defined as p < 0.05.
N/A Not applicable due to non-significance on bivariate analysis with complication, defined as p > 0.05.